Sartorius Stedim Biotech S.A. (EPA:DIM)
France · Delayed Price · Currency is EUR 163.30
-2.20 (-1.33%)
Jun 19, 2026, 5:35 PM CET
Sartorius Stedim Biotech Stock Forecast
Stock Price Forecast
According to 14 analysts polled by S&P Global, Sartorius Stedim Biotech stock has a consensus rating of "Buy" and an average price target of €232.21. The average 1-year stock price forecast is 42.20% higher than the current stock price, while the lowest is €210.00 (+28.60%) and the highest is €262.00 (+60.44%).
Price Target: €232.21 (+42.20%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Sartorius Stedim Biotech stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 7 | 7 | 7 | 7 |
| Buy | 4 | 4 | 6 | 6 | 6 | 6 |
| Hold | 5 | 5 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 14 | 14 | 14 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HSBC | HSBC | Buy Maintains €233.00 → €230.00 | Buy | Maintains | €233.00 → €230.00 | +40.85% | Jun 3, 2026 |
| RBC Capital | RBC Capital | Buy Maintains €210.00 | Buy | Maintains | €210.00 | +28.60% | May 6, 2026 |
| Barclays | Barclays | Buy Maintains €220.00 | Buy | Maintains | €220.00 | +34.72% | Apr 23, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains €260.00 | Buy | Maintains | €260.00 | +59.22% | Apr 23, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains €214.00 | Buy | Maintains | €214.00 | +31.05% | Apr 23, 2026 |
Financial Forecast
Revenue This Year
3.17B
from 2.97B
Increased by 6.83%
Revenue Next Year
3.50B
from 3.17B
Increased by 10.46%
EPS This Year
5.04
from 4.40
Increased by 14.65%
EPS Next Year
6.05
from 5.04
Increased by 19.95%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 3.2B | ||
| Avg | 3.2B | ||
| Low | 3.1B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 7.9% | ||
| Avg | 6.8% | ||
| Low | 5.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 5.31 | ||
| Avg | 5.04 | ||
| Low | 4.54 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 20.7% | ||
| Avg | 14.6% | ||
| Low | 3.2% |